Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CARDLYTICS, INC. (CDLX)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Market reaction Comment Full text

XENCOR INC (XNCR)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Xencor Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

VANDA PHARMACEUTICALS INC. (VNDA)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

CAPITAL BANCORP INC (CBNK)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

Market reaction Comment Full text

BLACK DIAMOND THERAPEUTICS, INC. (BDTX)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 2
  • 1 comments

Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Market reaction Comment Full text

SUNRUN INC. (RUN)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Sunrun Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

EXPEDIA GROUP, INC. (EXPE)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Expedia Group Reports Second Quarter 2026 Results

Market reaction Comment Full text

SYNDAX PHARMACEUTICALS INC (SNDX)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Market reaction Comment Full text

MERCADOLIBRE INC (MELI)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 1
  • 1 comments

MercadoLibre, Inc. Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

BLEND LABS, INC. (BLND)

  • Business News
  • Aug. 05, 2026, 20:01 UTC
  • 2
  • 1 comments

Blend to Present at the Canaccord Genuity 46th Annual Growth Conference

Market reaction Comment Full text
  • Previous
  • 271
  • 272
  • 273
  • 274
  • 275
  • Next

Search

News categories

  • Technical Exchange News(14174)
  • Event(6229)
  • SEC News(361398)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222314)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin